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Background: lynx1 reduces sensitivity of 42 nAChRs in vitro and also reduces nicotinic responses in vivo.
Results: The GPI protein, lynx1, affects 4/4 dimer formation in the ER, altering plasma membrane 42 stoichiometry.
Conclusion: nAChR modulation can occur as early as the ER, by biasing the starting material for receptor assembly.
Significance: Acute pharmacology and behavior caused by PM nAChRs may be modified by molecules governing nAChR
assembly.
Glycosylphosphatidylinositol-anchored neurotoxin-like recep-
tor binding proteins, such as lynx modulators, are topologically
positioned to exert pharmacological effects by binding to the
extracellular portion of nAChRs. These actions are generally
thought to proceed when both lynx and the nAChRs are on the
plasmamembrane. Here, we demonstrate that lynx1 also exerts
effects on 42 nAChRs within the endoplasmic reticulum.
Lynx1 affects assembly of nascent4 and2 subunits and alters
the stoichiometry of the receptor population that reaches the
plasma membrane. Additionally, these data suggest that lynx1
shifts nAChR stoichiometry to low sensitivity (4)3(2)2 pen-
tamers primarily through this interaction in the endoplasmic
reticulum, rather than solely via directmodulation of activity on
the plasma membrane. To our knowledge, these data represent
the first test of the hypothesis that a lynx family member, or
indeed any glycosylphosphatidylinositol-anchored protein,
could act within the cell to alter assembly of a multisubunit
protein.
Cholinergic systems are involved in diverse functions includ-
ing mood, anxiety, learning andmemory, addiction, andmove-
ment disorders (1). The nicotinic acetylcholine receptors
(nAChRs)2 of the cholinergic system are comprised of 15 dif-
ferent subunits (1–10 and 1–4) that assemble into both
homopentameric receptors, such as (7)5, or (9)5, and hetero-
pentameric receptors, such as 42 (2). Subunit composition,
and even the position of specific subunits within pentamers,
can influence the biophysical, pharmacological, and cell biolog-
ical properties of the receptor, with profound effects on infor-
mation processing in neurons that express these nAChRs (3).
Subunit composition influences the properties of the two
possible pentameric stoichiometries of42 nAChRs, themost
abundant heteromeric nAChR subtype in the brain. In a termi-
nology that emphasizes their differences with respect to acute
pharmacology, the (4)3(2)2 receptors are known as low sen-
sitivity (LS) receptors, whereas (4)2(2)3 receptors are known
as high sensitivity (HS) receptors (3, 4). These two stoichiome-
tries exhibit different desensitization kinetics and respond dif-
ferently to chronic nicotine treatment. HS receptors are up-
regulated in response to nicotine, whereas LS receptors are
unaffected. This is thought to play an important role in mech-
anisms of nicotine addiction (5, 6). Additionally, subunit com-
position could possibly influence subcellular localization of
receptors on the plasma membrane (PM).
The lynx family proteins are a subset of the Ly6/uPAR super-
family. This superfamily is related to the elapid snake venom
toxin genes, such as -bungarotoxin, consisting of a three-fin-
gered folding motif and multiple internal disulfide bonds (7, 8).
-Bungarotoxin and other such toxins exemplify a highly con-
served receptor binding motif that apparently evolved from
lynx proteins (7–9). -Bungarotoxin and other toxins have
become widely used probes for the investigation of the proper-
ties of nAChR. Snakes inject these toxins into their prey; in
contrast, the role of a toxin-like molecule expressed within a
cell together with nAChRs has not beenwidely studied. Since the
discovery of lynx1, many other lynx family members have been
found, and several include GPI anchors (1, 9, 10). The GPI-linked
lynx1 and lynx2molecules are presumably present inmembranes
early in theexocytoticpathway, suchas theendoplasmic reticulum
(ER). Therefore, the existence of the GPI anchor on lynx1 and
lynx2 proteins could contribute to the structure, composition, or
function of nascent nAChRs as well.
The differential contributions of lynx genes to brain function
are influenced to a large degree by the regions of expression. For
instance, lynx1 is widely expressed throughout the brain, with
high levels in the cerebral cortex and hippocampus, playing a
role in learning and neuronal plasticity (11–13). The lynx2
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gene, in contrast, has a more restricted expression with high
levels in the fear/anxiety structure of the amygdala, and lynx2
KO mice display elevated fear and anxiety-related behaviors
(14). Selectivity for nAChR subunits (7 and 2 nAChRs) has
also been found for lynx1 proteins and could provide another
level of regulation not yet well explored.
GPI-anchored neurotoxin-like receptor binding proteins,
such as lynx modulators, are confined to a volume just a few
nanometers above the extracellular face of themembrane. This
topology positions them to exert effects by binding to the extra-
cellular portion of nAChRs. These actions have previously been
thought to proceed on the PM. Among the pharmacological
effects of small molecule ligands is pharmacological chaperon-
ing of 42 nAChRs; this proceeds when the ligands enter the
ER (6) and, perhaps, theGolgi (15). Thus far, there have been no
reports of lynx modulators exerting an effect inside cells. Here,
we investigated the hypothesis that lynx1 also exerts an effect
on 42 nAChRs within the ER. To our knowledge, these data
represent the first report of a lynx familymember, or indeed any
GPI-anchored protein, acting within the cell to alter assembly
of multisubunit proteins.
EXPERIMENTAL PROCEDURES
Plasmid Constructs—Mouse lynx1 cDNAs including an
N-terminally fused fluorescent tag (eGFP, mCherry, or SEP)
were constructed by PCR amplification using the forward
primer 5-gcctgcctgtggcccaggctatggtgagcaagggcgag-3 and the
reverse primer 5-aggcacacacgtggcactccagcttgtacagctcgtccat-
gcc-3, which overlap with both sequences before and after the
N-terminal signal sequence of the lynx1-coding sequence (see
Fig. 1A). Four XFP-lynx1 constructs were made with four dif-
ferent linkers separating the fluorescent tag frommature lynx1
(these are available fromAddgene): 1) no additional sequences,
2) Gly-Ser, 3) Gly-Gly-Ser-Gly, and 4) Tyr-Ser-Asp-Leu
(YSDL). All four variants are fluorescent, indicating that the
mCherry fluorophore folds properly. All experiments pre-
sented in this paper utilized the YSDL linker version of the
construct because it has been used previously with another
GPI-linked fusion protein, GFP-CD59 (16, 17),3 and it was
the first construct we validated via electrophysiology. This
PCR product was then cloned directly into the vector con-
taining the lynx1 gene using Pfu-Turbo DNA polymerase.
We used mouse 4-WT, a4-GFP, 4-mCherry, 2-WT,
2-GFP, and 2-mCherry cDNA clones inserted into pCI-
NEO vectors as described previously (18).
Tissue Culture and Transfection—Mouse neuroblastoma-2a
(N2a) cells were cultured using standard techniques and main-
tained in DMEM (Invitrogen) supplemented with 10% FBS.
N2a cells were plated by adding 90,000 cells to poly-D-lysine-
coated 35-mm glass bottom imaging dishes (MatTek, Ashland,
MA). The next day, plasmid DNA was mixed with cationic lip-
ids by adding 500–750 ng of each nAChR plasmid and lynx1
construct to 4 l of Lipofectamine 2000 transfection reagent in
200l of OptiMEM (Invitrogen). After 20min at room temper-
ature, the transfectionmixture was added toN2a cells in 1ml of
plating medium and incubated at 37 °C for 24 h. Dishes were
rinsed twice with platingmedium and incubated at 37 °C for an
additional 24 h before imaging or electrophysiological experi-
ments. HEK293 cells were also cultured using standard cell
techniques as detailed above. N2a cells and HEK293 cells were
obtained from ATCC (Manassas, VA).
Primary mouse embryonic day 16.5 neurons were extracted
from mouse embryos and plated on 35-mm polylysine-coated
glass bottom culture dishes (MatTek) in a neuronal medium
containing Neurobasal, B27 (Invitrogen), and GlutaMAX sup-
plemented with 3% equine serum. We defined this initial plat-
ing as day in vitro zero (DIV 0).Neuronswere plated at a density
of 60,000 cells/dish. On day 4 in vitro, neurons were treated
with 1 M cytosine arabinoside to halt the division of glial cells.
Neurons were maintained via 50% exchange with feeding
medium (Neurobasal, B27, andGlutaMAX) twice per week. On
day 9 in vitro, plasmids were mixed in 100 l of OptiMEM, and
4 l of Lipofectamine-2000 was mixed with a separate 100-l
aliquot of OptiMEM. After 5 min at room temperature, the
separate solutions were mixed together and kept at room tem-
perature for an additional 25 min. Neurons were transfected
with 750 ng of each nAChR plasmid and of XFP-lynx1 plasmid.
After 3 h at 37 °C, transfection mediumwas replaced with neu-
ronal feedingmedium.Neuronswere imaged on day 10 in vitro.
Co-immunoprecipitation—HEK293 cells were plated (on day
1) at a density of 4 million cells/10-cm dish. The cells were
transfected on day 2 with 5 g of each construct DNA using
ExpressFect reagent (Denville Scientific, South Plainfield, NJ)
according to the manufacturer’s protocol. On day 3, medium
was aspirated gently and replaced with fresh growth medium.
Cells were harvested on day 4 by removing cells from 37 °C
incubator, placing on ice, scraping cells from dish with a cell
scraper (Corning Inc., Corning, NY), and transferring cells to a
15-ml conical tube for centrifugation and lysis. Cells were lysed
in 1 ml of ice-cold Nonidet P-40 extraction buffer (50 mM Tris,
pH 7.4, 50 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 1 mM
EGTA, 1% P8340, and 4 mM PMSF) by gently pipetting up and
down 25 times. Cell lysate was centrifuged for 5min at 4 °C and
then combined with preformed complexes of protein A Dyna-
beads (Invitrogen) and rabbit-anti-GFP antibody (A11122;
Molecular Probes, Invitrogen) for immunoprecipitation at
room temperature on a rocker for 1 h. Dynabead-antibody-
antigen complexes were removed from the supernatant via
magnet andwashed. Complexes were dissociated by incubating
in reducing buffer (50% Laemmli sample buffer; Bio-Rad) for 10
min at 70 °C. Dissociated samples were removed frombeads via
magnet, allowed to cool on ice, and loaded into an SDS-PAGE
gel for Western blot analysis.
Western Blot—Samples were run on an SDS-PAGE protein
gel, transferred to a nitrocellulose membrane, blocked with
blocking buffer (TBS with 0.1% Tween 20 5% dry milk), and
probed with goat-anti-lynx primary antibody (sc-23060; Santa
Cruz Biotechnology, Santa Cruz, CA). Of three antibody lots
purchased from the supplier, only one gave satisfactory
results; unfortunately that lot is no longer available. Mem-
branes were probed with secondary IR800 anti-goat anti-
body (926–32214; Li-Cor Biosciences, Lincoln, NE). The
membranes were then imaged in an Odyssey near infrared
imager (Li-Cor Biosciences).3 P. Satpute and J. Lippincott-Schwartz, personal communication.
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ConfocalMicroscopy—N2a cells and neurons were imaged as
described previously (19, 20) in L15 buffer (150mMNaCl, 4mM
KCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, and 10 mM
D-glucose, pH 7.4), a CO2-independent medium. Briefly, cells
were imaged with a Nikon (Nikon Instruments, Melville, NY)
C1 laser-scanning confocal microscope system equipped with
spectral imaging capabilities and a Prior (Rockland, ME)
remote focus device, and a Nikon Plan Apo 60 1.40 NA oil
objective. Pinhole diameter was 30–60 m, and cells were
imaged at 12-bit intensity resolution over 512 512 pixels at a
pixel dwell time 6.72s. GFP was excited using a 488-nmmod-
ulated diode laser, andmCherrywas excitedwith an argon laser
at 561 nm. In most cases, imaging was carried out using the
Nikon C1si DEES grating and spectral detector with 32 parallel
photomultiplier tubes. This allowed us to collect spectral
images ( stacks). In such images, each pixel of the X-Y image
contains a list of emission intensity values across a range of
wavelengths. We collected light at wavelength intervals
between 485 and 650 nm, at steps of 5 nm. We used the Nikon
EZC1 linear unmixing algorithm to reconstruct GFP and
mCherry images. For each pixel of a spectral image, intensity of
GFP and mCherry was determined from fluorescence intensity
values at the peak emission wavelength derived from the refer-
ence spectra.
Phosphotidylinositol phospholipase C (PI-PLC) (catalog no.
37288-19-0, product no. P8804; Sigma-Aldrich) was used to
cleave theGPI anchor of lynx1 and thus cleave the protein from
the PM.After addition of 0.25 units/ml of PI-PLC to cell culture
dish, cells were incubated for 1 h at 37 °C either in amammalian
cell incubator or within a climate-controlled chamber on the
microscope stage (for before and after images). After PI-PLC
treatment, cells were briefly washed twice with 2 ml of fresh
medium and subsequently imaged. An aqueous glycerol solu-
tion buffer of 60% v/v glycerol, 10 mM Tris-HCl, 10 mM EDTA,
at a pH of 8.0 was used as a control with no PI-PLC enzyme.
Measuring FRET with Donor Recovery after Photobleaching
(DRAP)—To examine FRET between various nAChR subunits,
the acceptor photobleaching method was used with a modified
fluorescence recovery after photobleaching macro built into
theNikon EZC1 imaging software, as described previously (19).
In this method, FRET was detected by recording GFP signal
increases during incremental photodestruction of mCherry. A
spectral image was acquired once before mCherry bleaching
and at six time points during mCherry bleaching at 561 nm.
Laser power during bleaching was constant at 80%. One bleach
scan per cycle was used. This bleaching protocol was optimized
to achieve 75–90% photodestruction of mCherry while still
enabling us to record incremental increases in GFP emission at
each time point. To measure FRET, spectral images were
unmixed into theirGFP andmCherry components as described
above. We measured GFP and mCherry mean intensity
throughout the entire cell by selecting the cell perimeter as the
boundary of a region of interest in Nikon’s EZC1 software. GFP
andmCherry componentswere saved in Excel format, and fluo-
rescence intensities were normalized to the prebleach time
point (100%). FRET efficiency (E) was calculated as E  1 
(IDA/ID), where IDA represents the normalized fluorescence
intensity of GFP (100%) in the presence of both donor (GFP)
and acceptor (mCherry), and ID represents the normalized
fluorescence intensity of GFP in the presence of donor only
(complete photo destruction of mCherry). The ID value was
extrapolated from a scatter plot of the fractional increase of
CFP versus the fractional decrease of YFP. The E values were
averaged from several cells per condition.
Mammalian Cell Electrophysiology—N2a cells were co-
transfectedwith nAChR subunits taggedwith eGFP to facilitate
visual identification of transfected cells. We used an inverted
fluorescence microscope (IX71; Olympus) equipped with a
mercury lamp (HB-10103AF; Nikon) to visualize the fluores-
cent cells. Whole cell voltage-clamp currents were recorded
using an Axopatch-1D amplifier (Axon Instruments) and digi-
tized with a Digidata 1440A analog to digital converter (Axon)
under the control of pClamp 10.0 software (Axon). The pipette
solution contained 135 mM potassium gluconate, 5 mM KCl, 5
mM EGTA, 0.5 mM CaCl2, 10 mM HEPES, 2 mM Mg-ATP, and
0.1 mM GTP (pH adjusted to 7.2 with Tris-base, osmolarity to
280–300 mOsm with sucrose). Electrode resistance was 2–6
M. All recordings were obtained at ambient temperature.
Data were low pass filtered at 2 kHz and sampled at 10 kHz.
ACh was dissolved in an extracellular solution containing 140
mMNaCl, 5 mM KCl, 2 mM CaCl2, 1 mMMgCl2, 10 mMHEPES,
and 10 mM glucose (320 mOsm, pH to 7.3 with Tris-base) and
applied to cells using a Picospritzer (20 p.s.i.) or a commercially
available microperfusion system (Octaflow II; ALA Scientific
Instruments). The holding potential was50mV.Tominimize
agonist-induced desensitization, we applied ACh at 3-min
intervals and continually perfused the recording chamber with
extracellular solution.
PI-PLC was used to cleave lynx1 from the PM. We exposed
cells to 0.25 units/ml for 1 h at 37 °C incubation prior to elec-
trophysiology assays.
Statistical Analysis—Concentration-response relations for
the ACh-induced fluorescentmembrane potential changes and
voltage-clamp currents were fit to the Hill equation using non-
linear least squares regression (OriginLab software). The errors
reported for the mean values are	 S.E. Statistical significance
was determined by either Student’s t test or by one-way analysis
of variance where multiple pairwise comparisons were con-
ducted. Significant differences are reported at the level of p 

0.05 (*), p
 0.01 (**), or p
 0.001 (***).
RESULTS
Observations of XFP-lynx1 Reveal Localization Both in the
Endoplasmic Reticulum and on the Plasma Membrane—We
initially studied anmCherry-lynx1 construct. ThemCherrywas
inserted after the N-terminal signal sequence, followed by a
linker with sequence YDSL, and by the mature lynx1 protein
sequence as shown in Fig. 1A. This linker was previously char-
acterized on an analogous fluorescent GPI-linked fusion pro-
tein, GFP-CD59 (16). After electrophysiological validation of
the mCherry-linked construct (see Figs. 3 and 5 below), we
made two additional constructs by replacing the mCherry
sequence with that of GFP or superecliptic pHluorin (SEP).
To test the similarity of the GFP andmCherry constructs, we
co-transfected them together into cultured mouse embryonic
day 16.5 cortical neurons (Fig. 1B). The two constructs are co-
Lynx1 Affects42 nAChR Assembly
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localized in much of the cytoplasm, both in somata and den-
drites. We compared this distribution with that of two other
proteins. We co-transfected GFP-lynx1 with tau1-mCherry
(Fig. 1C). The tau1-mCherry localizes tomicrotubules. Inmany
neurons, GFP-lynx1 fluorescence displayed streaks, disconti-
nuities, and open areas not displayed by tau1-mCherry fluores-
cence (Fig. 1C), suggesting that lynx1 may normally be present
in restricted regions. GPI-anchored proteins, including those in
the Ly6/uPAR family, are often found in cholesterol-richmem-
brane domains; as explained in the next paragraph, restriction
to cholesterol-rich domains does not fully explain the distribu-
tion of lynx1. When co-transfected with GalT-mCherry, GFP-
lynx1 showed little overlap (Fig. 1D), indicating thatmost lynx1
molecules do not accumulate preferentially in the trans-Golgi
network.
SEP is a pH-sensitive variant of GFP with a pKa of7.0. SEP
is fluorescent at pH 7.4 but is quenched at pH 
 7.0 (22). Pre-
viously, when linked to the extracellular portion of Cys loop
receptors and other membrane proteins, SEP has provided evi-
dence that a portion of the tagged protein is present in intracel-
lular compartments, as well as on the PM (15, 23–25). For the
present study, once the SEP construct was verified electro-
physiologically (see Figs. 3 and 5 below), the SEP method pre-
sented several advantages over conventional studies using
immune reagents and cell permeabilization. First, the entire
experiment was performed on live neurons or clonal cells. Sec-
ond, not all neurons or clonal cells express the intended protein
after transfection; therefore, it was essential to use each cell as
its own control. Because the quenching and dequenching of PM
fluorescence is reversible, this was accomplished by imaging
the neurons or clonal cells before, during, and after perfusion
with low pH. Third, the SEPmethod, but not the permeabiliza-
tion/immune method, can distinguish between the presence of
the molecule in neutral versus acidic organelles. These consid-
erations rendered the SEP construct the reagent of choice
Weused this pHdependence of SEP to visualize and discrim-
inate between SEP-lynx1molecules residing intracellularly ver-
sus those residing on the PM, as shown in Fig. 1E. Five to six
minutes after the pH was adjusted to 5.5 by perfusion, we
observed that fluorescence decreased only partially in each of
10 cells examined, suggesting that a population of SEP-lynx1
resides in an organellewith pH 7.0. The two candidate organ-
elles are the ER and the cis-Golgi. The Golgi compartment is
much smaller than the ER and does not appear to accumulate
appreciable lynx1 (Fig. 1D). Furthermore, the fluorescent image
remaining at pH 5.5 overlaps substantially with the image from
co-transfected ER-dsRED (Fig. 1E). We conclude that SEP-
lynx1 resides at least partially in the ER.Analogous experiments
have previously shown that the extracellular face of nAChRs
resides partially in the ER (15, 24).
lynx1 Binds4-GFP in the ER—Previous assays onHEK293T
cells transfected with 4, 2 (both FLAG-tagged constructs),
and lynx1, immunoprecipitation of either 4 with anti-4 anti-
body (mAb299), or immunoprecipitation of both 4 and 2
FIGURE 1. Lynx1 is present in ER in addition to the PM. A, schematic of GFP, mCherry, or SEP insertion after the N-terminal signal sequence of lynx1. B–E,
cultured mouse neurons transfected with various fluorescently tagged proteins. B, both GFP-lynx1 and mCherry-lynx1. C, GFP-lynx1 and tau1-mCherry, a
marker for microtubules, partially co-localize. D, GFP-lynx1 and GalT-mCherry, indicating that the majority of lynx1 is outside the Golgi. E, SEP-lynx1 and
ER-dsRED, at both pH 7.4 and 5.5. Partial quenching of SEP at pH 5.5 indicates that lynx1 is present in the ER as well as on the plasma membrane. F, topology
of an4- or2-GFP construct.4- or2-GFP nAChRswere labeledwith SEP at the extracellular N-terminus in a previous study (24), andwith GFP inserted into
the intracellular M3-M4 loop (present study). The cartoon of nAChR derives from PDB 2BG9, and the cytoplasmic portions are incomplete. G, co-immunopre-
cipitation of GFP-tagged 4 subunits with an anti-GF antibody indicates that lynx1 binds and forms stable complexes with 4-GFP both with 2 present (lane
1) and with no other nAChR subunits present (lane 2). 4 subunits alone are unable to leave the ER; thus lynx1 must bind in the ER. lynx1 was not detectable
when either co-transfected with 2-GFP (lane 3) or alone (lane 4).
Lynx1 Affects42 nAChR Assembly
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with anti-FLAG antibodies showed co-immunoprecipitation of
nAChRs with lynx1 (26). Here, we demonstrate that lynx1 and
4 also co-immunoprecipitate when the 2 subunit is omitted
(Fig. 1G). Because 4 subunits alone do not form a complete,
pentameric receptor, they do not efficiently leave the ER (27).
To test whether lynx1 could bind the individual subunits of
the 42 nAChR and potentially affect assembly, we co-trans-
fected either: 1) 4-GFP, 2-WT, and lynx1; 2) 4-GFP and
lynx1; 3)2-GFP and lynx1; or 4) lynx1 alone intoHEK293 cells
(Fig. 1, F and G). We probed for lynx1 after precipitating the
nAChR subunits with an anti-GFP antibody. We found that
when 4 is present, either alone or with 2, lynx1 was pulled
down. We could not detect lynx1 when 2-GFP alone was co-
transfected with lynx1 and immunoprecipitated or in the con-
trol where there was no nAChR subunit co-transfected (Fig.
1G). Because it appears that lynx1 can bind the4 subunit with-
out the presence of 2, we conclude that lynx1 is able to bind to
4 before pentamers are formed, suggesting that association of
lynx1 with 4 occurs in the ER.
lynx1 Stabilizes 4/4 Dimers, but Not 2/2 Dimers, in the
ER—Tomeasurewhether the presence of lynx1 affects receptor
formation, we conducted four types of DRAP FRET experi-
ments on mouse N2a cells transfected with nAChR subunits
plus or minus lynx1 (Fig. 2). We co-transfected 4-GFP,
4-mCherry, and either empty vector or lynx1 (we did not co-
transfect a subunit). In this case, wemeasuredDRAPbetween
4/4 dimers in the ER, because 4 without a  subunit cannot
assemble into a full pentamer and subsequently cannot effi-
ciently exit the ER. The addition of lynx1 increased the FRET
efficiency between these dimers from 6.7	 1.13% (26 cells) to
14.59 	 1.51% (32 cells), suggesting that lynx1 binds 4 sub-
units in the ER, increasing dimerization and potentially assist-
ing the formation of the LS stoichiometry (Fig. 2,A,B, andE). In
another set of experiments, we obtained FRET measurements
between4-GFP and4-mCherry in the presence of2-WTof
9.33	 0.85% (40 cells) and 13.09	 1.11% (36 cells) with empty
vector and lynx, respectively. When we co-expressed fluores-
cently labeled 2 subunits, 2-GFP and 2-mCherry, either in
the presence or absence of4-WT, the addition of lynx1 did not
significantly alter the FRET efficiency (Fig. 2, B1, B2, C1, C2,
and E). For 2-GFP/2-mCherry with no 4-WT or lynx, the
FRET efficiency was 25.1 	 2.79% (31 cells); when lynx was
added, the FRET efficiency was 27.5 	 2.4% (24 cells). For
2-GFP/2-mCherry with 4-WT, the FRET efficiencies were
18.4 	 1.3% (29 cells) and 18.5 	 1.7% (33 cells) for co-trans-
fected empty vector and lynx, respectively. The data are
reported here as mean 	 S.E. (number of cells per condition).
The contrast in FRET efficiencies between the lynx1 condition
and the control condition persisted when the control transfec-
tion employed GAT1 cDNA instead of empty vector.
These data show that lynx1 increases the assembly of 4/4
dimers and does not alter 2/2 dimer assembly. To assess the
effect of lynx1 on fully assembled 42 nAChR pentamers, we
co-expressed 4-GFP, 4-mCherry, 2-WT, and either empty
vector (pcDNA3.1) or lynx1. The addition of lynx1 increased
the FRET between the fluorescently labeled 4 subunits, indi-
cating that lynx1 increases the extent to which 4 subunits
assemble together in complexes (Fig. 2E). This shift could be
due to increased incorporation of the 4 subunit into the aux-
iliary position of 42 fully formed pentamers (LS, (4)3(2)2
stoichiometry). It could also be due to increased 4/4 dimers
in the ER. These two outcomes are not mutually exclusive. In
FIGURE 2.DRAP.N2a cellswere transfectedwith either4-GFP and4-mCherry (A1,A2, B1, and B2 showexemplar data) or2-GFP and2-mCherry (C1,C2,D1,
and D2 show exemplar data). The acceptor fluorophore (mCherry) was photobleached, causing an increase in fluorescence of the donor fluorophore (GFP).
4-GFP and 4-mCherry were co-transfected either with empty vector (A1, A2) or with lynx1 (B1, B2). 2-GFP and 2-mCherry were co-transfected either with
empty vector (C1 andC2), orwith lynx1 (D1 andD2). Lynx1 increases FRET efficiencybetween4 subunits, but not between2 subunits. E, lynx1 increases FRET
efficiency between 4-GFP and 4-mCherry subunits when no other subunits are present (top left) and also when co-transfected with 2 (bottom left). lynx1
doesnot increase FRETefficiencybetween fluorescently tagged2 subunits eitherwithout4present (top right) orwith co-transfected4 (bottom right). F and
G, lynx1 has no effect on the ratio of signals, GFP/mCherry for fluorescently tagged 4 (F) or 2 (G). The numbers within parentheses in the bars represent
number of cells per condition.
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fact, the latter (increased 4/4 dimers in the ER) would likely
lead to the former by biasing assembly toward the formation of
(4)3(2)2 (LS) nAChRs. This would presumably result inmore
LS receptors being exported from the ER and eventually traf-
ficked to the PM.
Ahigh baseline level of acceptor or lowpost-acceptor bleach-
ing level of donor could distort the measurements of FRET
efficiency. To rule this out, we calculated the ratio betweenGFP
and mCherry expression (Fig. 2, F and G). We achieved ratios
consistently between 0.6 to 2.0, which are within the acceptable
range for DRAP measurements.
lynx1 Causes a Shift in Population Stoichiometry of the 42
nAChR on the Plasma Membrane—Previous studies on lynx1
showed that lynx1 reduces the sensitivity of 42 receptors to
ACh in heterologous expression systems and also to nicotine
responses in vivo (7, 12, 26).However, it has not been previously
demonstrated that lynx1 shifts the stoichiometry of 42
receptors on the PM by biasing assembly of nascent subunits
within the ER. To test this hypothesis, we completed a series of
electrophysiological assays (Fig. 3).
These electrophysiological experiments examined the effect
of lynx1 and fluorescently tagged XFP-lynx1 on 42. We
transfected N2a cells with 4-GFP and 2-WT nAChR sub-
units and either lynx1 (WT or mCherry) or empty vector. The
addition of lynx1-WT or mCherry-lynx1 reduced peak current
sizes, reduced the proportion of HS receptors, and decreased
the decay time (Fig. 3 and Table 1). Addition of lynx1-WT
reduced 42 nAChR peak current amplitude to 40% of the
maximal response (from 3280 	 1320 pA (5 cells) to 1,060, 	
402 pA (6 cells)) for lynx1-WT (Fig. 3,A, B, andD). Addition of
mCherry-lynx1 similarly reduced the 42 nAChR peak cur-
rent amplitude to30% of the maximal response (539.4	 115
pA (10 cells)) (Fig. 3, A, C, and D). There was no significant
difference between lynx1-WTandmCherry-lynx1 in regards to
mean peak current amplitude, decay time, or waveform (Fig. 3,
D and E). This suggests that the addition of the mCherry fluo-
rophore to lynx1 does not significantly alter its function.
Next we collected concentration-response data to assess
changes in 42 nAChR stoichiometry. Previous assays have
validated that the LS andHS42 nAChR stoichiometries have
distinct pharmacological profiles: LS nAChRs and HS nAChRs
have different EC50 values with ACh (30 and 3 M, respec-
tively) (5, 28). Without lynx1, 42 nAChRs have a two-com-
ponent concentration-response relation, with a pronounced
HS-like behavior at [ACh]  1 M (Fig. 3F). The addition of
lynx1 (WT or mCherry) produced less pronounced responses
at lower [ACh] (Fig. 3F). This suggests that in the presence of
lynx1, the HS (4)2(2)3 nAChR population is decreased.
Therefore, PM 42 nAChRs are composedmainly of LS 42
nAChRs. The Hill equation fits (Table 1) are consistent with a
shift in components. In the absence of lynx1, 50% of the
response is the HS component (as often observed in 42
experiments); but in each of the lynx1 conditions this is reduced
to 25–28% HS. A compelling contrast is shown for the nor-
FIGURE 3. Electrophysiology in N2a cells. lynx1-WT and mCherry-lynx1 have similar effects on 42. A–C, representative traces from N2a cells transfected
with 4-GFP, 2-WT, and either empty vector (A), lynx1-WT (B), or mCherry-lynx1 (C) where ACh was puffed for 100 ms. D, both lynx1-WT and mCherry-lynx1
decrease peak currents at 300 M ACh when compared with empty vector. E, traces from N2a cells when transfected with 42 and either lynx1-WT or
mCherry-lynx1. F andG, addition of lynx1 variants shifts the concentration-response curve of ACh on42 nAChRs to the right, toward a greater proportion of
the low sensitivity (4)3(2)2 stoichiometry. F, concentration-response curves of 42 nAChRs when co-transfectedwith empty vector, lynx1, mCherry-lynx1,
or lynx1 and treatment with PLC for 1 h at 37 °C. G, comparison of normalized current between 42 and lynx1 variant conditions at 10 M ACh. 10 M was
selected tomaximize activation of high-sensitivity (EC50 3M) stoichiometry (4)2(2)3 receptors, while minimizing activation of the lower sensitivity (EC50
 50 M) stoichiometry (4)3(2)2 receptors. The maximal response is significantly reduced for the three lynx1 variants. There is no significant difference
between lynx1, mCherry-lynx, and lynx1 plus PLC treatment. The numberswithin parentheses in the bars represent number of cells per condition.
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malized data at 10MACh (Fig. 3G), whichwas chosen because
this dose produces near maximal responses at HS receptors,
with minimal contribution by LS receptor (4, 5).
Ric3, another protein that affects nAChRexpression, appears
to act catalytically within the ER (29, 30). It has previously been
shown that lynx1 does not affect the function of GABAA recep-
tors in oocytes (26); we have not studied this point systemati-
cally in the present experiments.
PI-PLC Treatment Cleaves lynx1 from the Plasma Mem-
brane—We cleaved the GPI anchor of lynx1, releasing lynx1
from the PM via treatment with PI-PLC. This allowed us to
determine whether acute removal of surface lynx1 affects the
response of42 nAChRs. Using confocal imaging, we demon-
strate that we can remove lynx1 from the PM of N2a cells
expressing mCherry-lynx1 (Fig 4A), or co-expressing 42
nAChRs and mCherry-lynx1 (Fig. 4B). Before treatment with
PI-PLC, “railroad tracks” of red fluorescence are clear on the
borders of processes, indicatingmCherry-lynx1 on the PM, and
they are quantified by intensities in typical line profiles where
the peaks align with the borders. After PI-PLC treatment for
1 h, the membrane fluorescence is decreased and becomes
undetectable above background (Fig. 4, A and B). This can be
seen clearly through line profiles (Fig. 4, C and D). In control
experiments, cells were treated with identical solution lacking
PI-PLC, and we observed no reduction in PM railroad track-
like appearance or line profile quantification (data not shown).
PI-PLC Treatment Does Not Affect Concentration-Response
Relations to ACh, Peak Current, or Decay Kinetics of 42 
lynx1—Before and after treatment with PI-PLC to cleave lynx1,
we performed electrophysiological experiments to measure
concentration-response relations to ACh (Fig. 3F). After PI-
PLC treatment, the peak currents and concentration response
curve were not different when compared with lynx1-WT and
mCherry-lynx1 conditions (Fig. 3F). Peak current amplitude at
saturating concentrations of ACh (300M) and desensitization
kinetics (90% to 10% of maximal current) were similar between
lynx1-WT plus PI-PLC and lynx1-WTwithout PI-PLC (Fig. 5).
We confirmed earlier observations that the expression of lynx
does accelerate desensitization of 42 currents (12, 26). How-
ever, this acceleration is not reversed by PI-PLC treatment.
Overlay of 42 nAChRs with lynx1 (treated or not treated
with PI-PLC) shows a close overlap and little difference among
waveforms (Fig. 5D). These results suggest that the major
effects of lynx1 on 42 occur before the nAChRs appear on
the PM. The data together demonstrate that continued expres-
sion of lynx on the PM is not necessary for maintenance of its
effects on 42 and suggest that lynx1 may exert effects intra-
cellularly by stabilizing 4/4 dimers in the ER, thus favoring
the LS (4)3(2)2 stoichiometry.
DISCUSSION
Our data lead to three conclusions. First, lynx1 binds 4
nAChR subunits in the ER and increases 4/4 dimer forma-
tion. Second, lynx1 biases the stoichiometry of 42 receptors
toward LS (4)3(2)2 nAChR pentamers. Finally, the minimal
effects of removing lynx1 at the PM suggest that lynx1 exerts its
effects on nascent receptors within the ER, thereby influencing
receptor assembly and the stoichiometry of the final receptor
exported to the PM. To our knowledge, this is the first report of
a GPI-anchored protein playing a role in regulating assembly of
a multimeric protein through an intracellular mechanism.
It has been previously demonstrated that the expression
of lynx1 reduces the sensitivity of 42 nAChRs, and knock-
out of the lynx1 gene increases sensitivity (12, 26). The molec-
ular mechanisms for these actions, however, had yet to be
addressed. Taking into account the relationship between lynx
genes and snake venom toxins, a straightforwardmechanism of
lynx binding to the extracellular portion of the receptor on the
cell surface to influence gating has been the assumed mode of
action for lynx proteins (7, 8). In this study, we applied new
tools to demonstrate that lynx1 is resident both on the cell
surface and in the interior of the cell. Apparently, the internal
lynx1/4 interactions are dominant, because removing surface
lynx had little effect on receptor function. The most likely
mechanism is that lynx1 controls the functional properties of
nAChRs by influencing the type and number of receptors dur-
ing receptor assembly in the ER.
If lynx1 does exert a functional gating effect on PM 42
nAChRs, it may be effective after cleavage of the GPI anchor
and/or at very high concentrations. Indeed, exogenously
applied lynx1 (minus the GPI anchor) alters the peak response
of 42 nAChRs to nicotine and ACh in vitro (7). Further,
previous studies in vivo show that overexpression of secreted
lynx1 inmouse cerebellum, a region involved inmotor learning,
results in enhanced motor learning (13), a behavioral pheno-
type similar to the lynx1 KO mice. Our results cannot defini-
tively exclude a mechanism by which the lynx1 proteins that
were previously bound to receptors prior to PI-PLC treatment
TABLE 1
Comparison of two-component fits to 42 concentration-response relations in N2a cells when co-transfected with empty vector, or one of
three lynx1 conditions
lynx1, mCherry-lynx1, or lynx1 plus PLC treatment was used. Fits were generated under two assumptions: 1) all HS receptors, and no LS receptors, are activated at 10 M
ACh, and 2) Hill coefficients were constrained to 1.5. Fitted parameters for ACh concentration-response relations of 42 when co-transfected with empty vector,
lynx1-wt, mCherry-lynx1, and lynx1-wt after treatment with PI-PLC. Parameters correspond to ACh concentration-response relations in Fig. 3. The EC50 and Hill
coefficient values represent the means	 S.E. for the number of measurements (n) obtained. The relative fraction of the high sensitivity component (first component) for
the biphasic relations is included.
HS LS
42 ACh EC50
EC50
error n
n
error EC50
EC50
error n
n
error HS R2
%
WTpcDNA 2.34 1.38 0.86 0.43 36.9 20.1 1.5 0.76 50.3 0.97
lynx-pTracer 5.42 3.36 1.5 1.18 61.4 14.1 1.5 0.44 27.0 0.99
mC-lynx 2.49 1.41 1.05 0.76 58.6 12.8 1.5 0.37 28.4 0.99
LynxPLC 6.55 9.47 0.54 0.41 41.9 14.7 1.5 0.37 24.9 0.99
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remained bound after GPI anchor cleavage. In this scenario,
these interactionsmay have continued to influence gating func-
tion, but the concentration of bound lynx molecules was below
the detection threshold of our confocal imaging assay.
Single-channel studies of 42 and lynx1 in CHO cells indi-
cate a shift in the proportion of channel openings toward higher
amplitude, faster inactivating species (26). The two different
amplitudes of single channel openings may arise from the two
different stoichiometries, where the (4)3(2)2 stoichiometry
mediates larger amplitude openings (28). The interactions of
lynx1 and 4/4 subunits are likely to increase the internal
concentration of total 4/4 interfaces, and because an 4/4
interface occurs only in the (4)3(2)2 nAChR stoichiometry,
this could explain the greater expression of (4)3(2)2 nAChRs
when lynx1 is present. Because (4)3(2)2 nAChRs are also
thought to inactivate more rapidly, the accelerated decay of the
macroscopic current in cells co-transfectedwith lynx1might be
explained by this stoichiometry shift. A lynx1-based model of
FIGURE 4. PI-PLC treatment cleaves mCherry-lynx1 from the plasma membrane. A, images of N2a cells transfected with mCherry-lynx1 before (left) and
after (right) treatment with PI-PLC. Lower, line profiles quantifying fluorescence levels, demarcated as awhite bar in upper images. AFU, arbitrary fluorescence
units. B, images of N2a cells transfected with 4-GFP, 2-WT, and mCherry-lynx1 taken with a confocal microscope before (B, upper) and after (B, lower)
treatment with PI-PLC. C and D, line profiles quantifying fluorescence levels across a line demonstrate the presence of the railroad track morphology of
mCherry-lynx1 on themembrane of N2a cells before treatment with PI-PLC (C) and after (D). The arrows point to the lines used for quantification. 100 pixels
10 m. These data are typical of five experiments.
FIGURE 5. PLC treatment does not affect ACh-induced currents of cells transfected with 42 and lynx1. A–C, representative traces from N2a cells
transfected with 4, 2, and either empty vector (A), lynx1 (B), or lynx1 with subsequent PLC treatment (C). Cells were subjected to 100 M ACh for 10 s to
measure both peak current and desensitization (quantified here as the time between 90 and 10%ofmax current).D, overlay of traces comparing lynx1with or
without PLC treatment. E and F, PLC does not alter peak current (E) or decay time (F) of N2a cells transfected with 4, 2, and lynx1. However, lynx1 does
decrease the decay time compared with 42 alone both without and with PLC treatment. F presents a shift in 90% to 10% decay time from 6.14	 0.55 s for
empty vector to 2.35	 0.37 s and 2.68	 0.46 s for lynx-WT and lynx1-WT PLC, respectively
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pentameric receptor assembly might be slightly different from
those previously put forth. It is generally thought that 4/2
dimers are formed first, and the fifth position is filled by either
an4 or2 subunit. The lynx1-nAChR interactionmight affect
this final step, in favor of incorporating 4 subunits. Increasing
the 4/4 population may influence the expression of fully
formed receptors, resulting in both greater selectivity (shift in
stoichiometry) and less efficiency (reduction in the total num-
ber of receptors).
The ratio of 4 and 2 subunits has been a well documented
determinant for 42 stoichiometry (24). With the data pre-
sented here, it is likely that a preferential affinity for 4 mono-
mers by lynx1 underlies stoichiometry shifts, although we can-
not rule out the possibility that 4 and 2 subunit levels are
altered by the presence of lynx1. Indeed, if lynx1 is acting as a
catalyst for dimer formation, it could be acting on other sub-
units (e.g.2), but if those other subunits are at sufficiently high
concentrations, the effect of lynx1 may not be detected. There
are several reasonswe do not believe this to be happening. First,
in our system, we do not see a demonstrably higher level of 2
subunit transcription, as compared with 4, or changes in
receptor protein levels caused by lynx.Also, lynx1 does not bind
when only2 is overexpressedwith lynx in cells, nor does it add
to 2 FRET efficiency. These data indicate affinity differences
of lynx1 toward 4 over 2 subunits. All things being equal, the
addition of lynx1 to the system appears to drive the formation
of 4/4 dimers with a shift in stoichiometry as a consequence
of that affinity difference.
Indeed, although we have not detected differences in receptor
subunit levels, we do find that 2 subunits appear to make more
natural pairs than4 subunits do; in Fig. 2E, the FRETefficiency is
higher in the2only condition (irrespectiveof lynxpresence) than
the 4 only condition. It appears that 4 subunits benefit from a
helper molecule to aid the formation—hence increasing the con-
centration—of 4/4 dimers. This might provide a teleology for
the lynx1 gene, in its ability to shape nAChR responsiveness
through subunit affinity differences.
The elapid neurotoxins, such as -bungarotoxin and -cobra-
toxin, apparently evolved from a lynx gene (9). The selective
advantageof theneurotoxinsarises frombindingasantagonists, to
/non- interfaces ofmuscle nAChRs.-Bungarotoxin also binds
to 7 nAChRs via 7/7 interfaces. This study shows that lynx1
binds to4/4 interfaces.We do not yet know atwhich interfaces
and inwhichsubcellularcompartment lynx1binds tootherhomo-
multimericandheteromultimericnAChRs. It is interesting tonote
thatnicotinebinds to/ interfaces, andprolongednicotinebind-
ing within the ER is thought to up-regulate 42 nAChRs by sta-
bilizing the (4)2(2)3 stoichiometry (15, 31–33).Ourdata suggest
that lynx1 could oppose some of the effects of chronic nicotine by
shifting the dimer concentration toward the 4/4 species (26).
The differential up-regulation by chronic nicotine exposure in the
brain may be due in part to the differential expression of lynx1
genes in different neuronal cell types. In the future, we would like
to study interactions between lynx1 and nicotine effects.
As noted above, our data remain consistent with the possi-
bility that nAChR-lynx1 interactions, which begin in the ER,
could continue throughout the lifetime of the receptor. The
diminution of peak ACh-mediated currents caused by lynx1 is
somewhat greater than would be explained by loss of the HS
component; perhaps lynx1 also affects receptor turnover at the
PM. This presents the possibility of a multimodal action of
lynx1 on several aspects of cholinergic signaling. This should be
taken into account when one considers models of lynx1 action
on the function of the cholinergic system in the brain. The
control that lynx1 exerts on cholinergic tone through nAChR
interactions (1, 9, 11) makes lynx1 a reasonable target for phar-
maceutical drug development. Several drug candidates target-
ing nAChRs are in development (34–37), and some may act by
potentiating nAChRs (37–41). One potential drawback of
strategies involving agonists or partial agonists is the uncer-
tainty of either receptor activation or desensitization, or both
(42, 43). The lynx family proteins appear to increase the rate of
desensitization of nAChRs (14, 21), and their removal results in
nAChRs exhibiting less receptor desensitization. Therefore,
inhibition of the endogenous action of lynx proteins may
achieve the possibly desirable effect of increasing cholinergic
tone while reducing desensitization. Pharmaceutical develop-
ment now focuses on compounds acting on PM-localized tar-
gets. Our data suggest that it may be important to consider
intracellular mechanisms of action as well.
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